Jerome Hogge bought $349K of Claritev (CTEV)
Executed May 19 2025, disclosed May 20 2025, 1 day later.
Over the 21 trading sessions from the disclosed entry session (May 20 2025), the stock returned +48.3% (delay-adjusted); from the execution session (May 19 2025), +48.2%. Derived: entry at the session's open, exit at the close 20 sessions later.
Jerome Hogge (EVP, Chief Operating Officer) filed 2 Form 4 reports in the past 24 months (2 purchases, 0 sales), most often in Claritev Corporation (CTEV). Across 2 priced purchase filings, the average 21-session return was +42.5% from execution and +37.1% from disclosure (delay-adjusted; derived). The largest single filing was $349K of CTEV (12,500 sh × $27.94, as filed), executed May 19 2025.
Healthcare · Claritev Corporation, together with its subsidiaries, provides data analytics and technology-enabled end-to-end cost management, payment, a…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→5,621 sh × $53.51
Exec Aug 7 2025
Filed Aug 11 2025 · 4:21 PM ET